Search Results - "Abbasi, Shawn A."

Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2 by Chan, Kui K, Dorosky, Danielle, Sharma, Preeti, Abbasi, Shawn A, Dye, John M, Kranz, David M, Herbert, Andrew S, Procko, Erik

“…The spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds angiotensin-converting enzyme 2 (ACE2) on host cells to initiate…”
Get full text

Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes by Voss, William N, Hou, Yixuan J, Johnson, Nicole V, Delidakis, George, Kim, Jin Eyun, Javanmardi, Kamyab, Horton, Andrew P, Bartzoka, Foteini, Paresi, Chelsea J, Tanno, Yuri, Chou, Chia-Wei, Abbasi, Shawn A, Pickens, Whitney, George, Katia, Boutz, Daniel R, Towers, Dalton M, McDaniel, Jonathan R, Billick, Daniel, Goike, Jule, Rowe, Lori, Batra, Dhwani, Pohl, Jan, Lee, Justin, Gangappa, Shivaprakash, Sambhara, Suryaprakash, Gadush, Michelle, Wang, Nianshuang, Person, Maria D, Iverson, Brent L, Gollihar, Jimmy D, Dye, John, Herbert, Andrew, Finkelstein, Ilya J, Baric, Ralph S, McLellan, Jason S, Georgiou, George, Lavinder, Jason J, Ippolito, Gregory C

“…The molecular composition and binding epitopes of the immunoglobulin G (IgG) antibodies that circulate in blood plasma following SARS-CoV-2 infection are…”
Get full text

A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition by Dieterle, M. Eugenia, Haslwanter, Denise, Bortz, Robert H., Wirchnianski, Ariel S., Lasso, Gorka, Vergnolle, Olivia, Abbasi, Shawn A., Fels, J. Maximilian, Laudermilch, Ethan, Florez, Catalina, Mengotto, Amanda, Kimmel, Duncan, Malonis, Ryan J., Georgiev, George, Quiroz, Jose, Barnhill, Jason, Pirofski, Liise-anne, Daily, Johanna P., Dye, John M., Lai, Jonathan R., Herbert, Andrew S., Chandran, Kartik, Jangra, Rohit K.

“…There is an urgent need for vaccines and therapeutics to prevent and treat COVID-19. Rapid SARS-CoV-2 countermeasure development is contingent on the…”
Get full text

Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19 by Frumkin, Lyn R., Lucas, Michaela, Scribner, Curtis L., Ortega-Heinly, Nastassja, Rogers, Jayden, Yin, Gang, Hallam, Trevor J., Yam, Alice, Bedard, Kristin, Begley, Rebecca, Cohen, Courtney A., Badger, Catherine V., Abbasi, Shawn A., Dye, John M., McMillan, Brian, Wallach, Michael, Bricker, Traci L., Joshi, Astha, Boon, Adrianus C. M., Pokhrel, Suman, Kraemer, Benjamin R., Lee, Lucia, Kargotich, Stephen, Agochiya, Mahima, John, Tom St, Mochly-Rosen, Daria

“…COVID-19 emergency use authorizations and approvals for vaccines were achieved in record time. However, there remains a need to develop additional safe,…”
Get full text

Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodies by Wirchnianski, Ariel S, Nyakatura, Elisabeth K, Herbert, Andrew S, Kuehne, Ana I, Abbasi, Shawn A, Florez, Catalina, Storm, Nadia, McKay, Lindsay G A, Dailey, Leandrew, Kuang, Erin, Abelson, Dafna M, Wec, Anna Z, Chakraborti, Srinjoy, Holtsberg, Frederick W, Shulenin, Sergey, Bornholdt, Zachary A, Aman, M Javad, Honko, Anna N, Griffiths, Anthony, Dye, John M, Chandran, Kartik, Lai, Jonathan R

“…Monoclonal antibodies (mAbs) are an important class of antiviral therapeutics. MAbs are highly selective, well tolerated, and have long in vivo half-life as…”
Get full text